Prognostic factors for recurrence and survival in human breast cancer

Breast Cancer Research and Treatment

Volumn 10, Issue 1, 1987, Pages 5-9

  McGuire, Wiliam L ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

aneuploidy; estrogen receptor; flow cytometry; HER 2 neu; nodal status; oncogene; progesterone receptor; prognosis; proliferative rate; S phase

Indexed keywords

STEROID RECEPTOR;

ARTICLE; BREAST TUMOR; FEMALE; GENE AMPLIFICATION; GENETICS; HUMAN; MORTALITY; ONCOGENE; PATHOLOGY; PROGNOSIS; RISK FACTOR; TUMOR RECURRENCE;

BREAST NEOPLASMS; FEMALE; GENE AMPLIFICATION; HUMAN; NEOPLASM RECURRENCE, LOCAL; ONCOGENES; PROGNOSIS; RECEPTORS, STEROID; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023423660     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/BF01806129     Document Type: Article

References (8)

1. Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer
2. Progesterone receptor as a prognostic factor in Stage II breast cancer
3. Cell kinetics in selection and stratification of patients for adjuvant therapy of breast carcinoma
4. Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancer
5. The long-term prognostic significance of the thymidine labelling index in breast cancer
6. Impact of flow cytometry on predicting recurrence and survival in breast cancer patients
7. The emerging impact of flow cytometry in predicting recurrence and survival in breast cancer patients
8. Amplification of the HER-2/neu oncogene correlates with relapse and survival in human breast cancer